Literature DB >> 10342067

Serum soluble transferrin receptor in the diagnosis of iron deficiency in chronic liver disease.

A Nagral1, A B Mehta, A T Gomes, G Ellis, B F Jackson, C A Sabin, N McIntyre.   

Abstract

Fifty-one consecutive patients with chronic liver disease (CLD) underwent investigations of their iron status (full blood count, serum iron [Fe], total iron binding capacity [TIBC], transferrin saturation [TS], serum ferritin and serum soluble transferrin receptor [sTfR] level). Twenty-six patients were anaemic; 12 patients had iron deficiency, and 10 had iron deficiency anaemia (IDA). The median (range) sTfR in the IDA patients was 16.6 (11.2-24.8) mg/l. compared with 6.6 mg/l (11.2-24.8) in the 16 patients with anaemia due to other causes (P = 0.01). The sensitivity of sTfR for diagnosing iron deficiency in CLD was 91.6% (100% if only anaemic patients are included) and the specificity was 84.6%. Patients with haemolysis and recent blood loss may have falsely elevated sTfR levels. The results suggest that the sTfR is as useful as serum ferritin in identifying a potentially treatable cause of anaemia in CLD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10342067     DOI: 10.1046/j.1365-2257.1999.00202.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  3 in total

Review 1.  Iron deficiency anemia in chronic liver disease: etiopathogenesis, diagnosis and treatment.

Authors:  Eleana Gkamprela; Melanie Deutsch; Dimitrios Pectasides
Journal:  Ann Gastroenterol       Date:  2017-05-03

Review 2.  Anemia in cirrhosis: An underestimated entity.

Authors:  Manish Manrai; Saurabh Dawra; Rajan Kapoor; Sharad Srivastava; Anupam Singh
Journal:  World J Clin Cases       Date:  2022-01-21       Impact factor: 1.337

3.  Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease.

Authors:  Derralynn Hughes; Maria Domenica Cappellini; Marc Berger; Jan Van Droogenbroeck; Maaike de Fost; Dragana Janic; Theodore Marinakis; Hanna Rosenbaum; Jesús Villarubia; Elena Zhukovskaya; Carla Hollak
Journal:  Br J Haematol       Date:  2007-07-26       Impact factor: 6.998

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.